XY Capital Ltd Trims Position in Koninklijke Philips N.V. $PHG

XY Capital Ltd reduced its stake in Koninklijke Philips N.V. (NYSE:PHG) by 62.1% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 24,413 shares of the technology company’s stock after selling 40,000 shares during the period. XY Capital Ltd’s holdings in Koninklijke Philips were worth $661,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Mondrian Investment Partners LTD purchased a new stake in Koninklijke Philips during the third quarter worth about $215,529,000. Causeway Capital Management LLC boosted its holdings in Koninklijke Philips by 5.8% in the third quarter. Causeway Capital Management LLC now owns 1,958,112 shares of the technology company’s stock valued at $53,378,000 after purchasing an additional 107,117 shares in the last quarter. Northern Trust Corp boosted its holdings in Koninklijke Philips by 8.1% in the third quarter. Northern Trust Corp now owns 1,922,551 shares of the technology company’s stock valued at $52,409,000 after purchasing an additional 143,811 shares in the last quarter. Brandes Investment Partners LP boosted its holdings in Koninklijke Philips by 6.6% in the fourth quarter. Brandes Investment Partners LP now owns 1,725,997 shares of the technology company’s stock valued at $46,740,000 after purchasing an additional 107,356 shares in the last quarter. Finally, Goldman Sachs Group Inc. boosted its holdings in shares of Koninklijke Philips by 1.8% in the fourth quarter. Goldman Sachs Group Inc. now owns 973,527 shares of the technology company’s stock valued at $26,363,000 after acquiring an additional 17,431 shares during the period. 13.67% of the stock is currently owned by hedge funds and other institutional investors.

Koninklijke Philips Price Performance

Koninklijke Philips stock opened at $26.13 on Friday. The business has a 50 day simple moving average of $27.01 and a 200-day simple moving average of $28.10. The stock has a market capitalization of $25.16 billion, a PE ratio of 22.39, a price-to-earnings-growth ratio of 6.62 and a beta of 0.74. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.32 and a quick ratio of 0.90. Koninklijke Philips N.V. has a 12 month low of $21.95 and a 12 month high of $33.44.

Koninklijke Philips (NYSE:PHG) last released its quarterly earnings data on Wednesday, May 6th. The technology company reported $0.27 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.24 by $0.03. The firm had revenue of $4.52 billion during the quarter, compared to analysts’ expectations of $4.49 billion. Koninklijke Philips had a return on equity of 13.51% and a net margin of 5.49%. Equities analysts predict that Koninklijke Philips N.V. will post 1.87 earnings per share for the current year.

Wall Street Analyst Weigh In

Several equities research analysts have recently weighed in on PHG shares. Zacks Research downgraded Koninklijke Philips from a “strong-buy” rating to a “hold” rating in a report on Monday, April 13th. Wall Street Zen raised Koninklijke Philips from a “hold” rating to a “buy” rating in a report on Saturday, May 2nd. Finally, Weiss Ratings downgraded Koninklijke Philips from a “buy (b-)” rating to a “hold (c+)” rating in a report on Thursday, April 2nd. Four equities research analysts have rated the stock with a Hold rating, According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold”.

Koninklijke Philips Profile

Koninklijke Philips N.V. (NYSE: PHG), commonly known as Philips, is a Dutch multinational company focused on health technology. Founded in Eindhoven in 1891, the company evolved from a diversified electronics manufacturer into a specialist in healthcare products, systems and services. Philips is legally registered in the Netherlands and operates globally, supplying equipment and solutions to hospitals, clinics, healthcare providers and consumers across Europe, the Americas and Asia.

Philips’ principal activities center on medical technologies and personal health.